Latest News
CTK’s OnSite Covid-19 Ag Rapid Tests detect newly identified U.K., South Africa, and Brazil SARS-CoV-2 variants
March 2, 2021
In December 2020, CTK shared that we had no reason to believe that the U.K. variant would affect the OnSite COVID-19 Ag Rapid Test’s performance, and we would work on confirmation studies. Since then, multiple SARS-CoV-2 variants have been circulating globally, which led us to...
Read More >Ongoing studies indicate that CTK’s OnSite Covid-19 IgG/IgM Rapid Tests detect antibodies in response to COVID-19 vaccines
February 24, 2021
CTK’s OnSite COVID-19 IgG/IgM Rapid Test’s performance in detecting antibody responses following COVID-19 vaccination was evaluated in a cohort of 20 subjects that had no detectable levels of anti-SARS-CoV-2 antibodies before vaccination. All 20 subjects (100%) had their first positive result on the OnSite COVID-19...
Read More >Events
Connect with CTK
Careers at CTK
CTK Biotech values knowledge, flexibility, and open communication to maintain the honest relationships within our team and our clients.
Help and Support
Whether you’re looking for answers or would like to solve a problem, we’ll help you resolve your issues quickly and easily.
Office
CTK Biotech, Inc.
13855 Stowe Drive
Poway, CA 92064
United States
Phone: 858.457.8698
Fax: 858.535.1739
Email: info@ctkbiotech.com